J&J unit snags cancer-fighting drug in deal with Berkeley's Aduro
May 29, 2014 at 11:35 AM EDT
Aduro BioTech Inc. could receive up to $365 million from a unit of Johnson & Johnson in a prostate cancer drug deal that focuses on a way to stimulate the body's immune system to attack tumor cells...